Clinical Trial Update: Efficacy/ Safety of Omalizumab in Patients With Seasonal Allergic Asthma and Seasonal Allergic Rhinoconjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of omalizumab in seasonal allergic asthma and seasonal allergic rhinoconjunctivitis has completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Asthma
• Seasonal Allergic Rhinitis
• Seasonal Allergic Rhinoconjunctivitis

Drugs mentioned

• Xolair (omalizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Allergic Asthma | Phase 3 | Status: COMPLETED | Results posted: 2011-06-03